Microbiology Testing/Clinical Microbiology Market by Application (Pharma, Clinical, Manufacturing, Environment), Disease (Respiratory Disease, STD, UTI), Product (Instrument, Analyzer, Reagent), End User (Hospital, Diagnolab, Academia) - Global Forecast to 2023

微生物検査/臨床微生物学の世界市場予測(~2023年)

◆タイトル:Microbiology Testing/Clinical Microbiology Market by Application (Pharma, Clinical, Manufacturing, Environment), Disease (Respiratory Disease, STD, UTI), Product (Instrument, Analyzer, Reagent), End User (Hospital, Diagnolab, Academia) - Global Forecast to 2023
◆商品コード:MD-3092
◆調査・発行会社:MarketsandMarkets
◆発行日:2018年6月27日
◆ページ数:224
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療装置
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、微生物検査/臨床微生物学の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、用途(製薬、臨床、製造、環境)別分析、疾患(呼吸器疾患、STD、UTI)別分析、製品(機器、分析装置、試薬)別分析、エンドユーザー(病院、診断ラボ、学術機関)別分析、微生物検査/臨床微生物学の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“The global clinical microbiology market is projected to grow at a CAGR of 6.4% in the next five years”The global clinical microbiology market is projected to reach USD 4.95 billion by 2023 from USD 3.63 billion in 2018, growing at a CAGR of 6.4% from 2018 to 2023. Key factors driving the growth of this market include ongoing technological advancements in the field of infectious disease diagnosis, rising incidence of infectious diseases and growing outbreak of epidemics, and increased funding and public-private investments for research and innovation. However, factors such as reimbursement concerns and unfavorable regulatory scenario are restraining the growth of this market to a certain extent.

“The reagents segment is projected to grow at the highest CAGR during the forecast period.”
By product, the clinical microbiology market is classified into instruments (laboratory instruments and microbiology analyzers) and reagents (pathogen-specific kits and general reagents). In 2018, the instruments product segment accounted for the largest share of the market, however, the reagents product segment is expected to grow at a higher rate during the forecast period. The growth of the reagents segment can be attributed to the high prevalence of infectious diseases across major markets, growing trend of reagent rental agreements along with instrument sales, and the increasing number of life science researches in the field of pathogen-specific reagents.

“Asia Pacific to witness the highest growth during the forecast period (2018-2023)”
North America is expected to hold the largest share of the global clinical microbiology market in 2018, however, Asia Pacific is expected to grow at the fastest rate during the forecast period. Factors such as the growing number of hospitals and clinical diagnostic laboratories in developing APAC countries; expanding research capabilities for the development of innovative and affordable clinical microbiology testing procedures across India, China, and Japan; and the rising incidence and prevalence of infectious diseases in the region.

Break-up of primary participants was as mentioned below:
• By Company Type – Tier 1–33%, Tier 2–46% and Tier 3–21%
• By Designation – C-level–26%, Director Level–20%, Others–54%
• By Region – North America–33%, Europe–29%, Asia Pacific–24%, RoW–14%
Note: RoW includes Latin America and the Middle East & Africa

Some of the major market players in the microbiology testing/clinical microbiology market are bioMérieux SA (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche AG (Switzerland), Bruker Corporation (US), Hologic, Inc. (US), QIAGEN N.V. (The Netherlands), Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Shimadzu Corporation (Japan), 3M Company (US), and Neogen Corporation (US), among others.

Research Coverage:
This report studies the microbiology testing market based on applications and region and the clinical microbiology market based on product, disease area, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and trends) which affect market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for key players. The microbiology testing/clinical microbiology market report profiles key players who are involved in the manufacturing and commercialization of microbiology testing products and analyzes their core competencies. The report also tracks and analyzes competitive developments in the market such as product launches and enhancements; acquisitions; partnerships and collaborations; and expansions.

Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help players capture larger market shares. Firms purchasing the report could use any one or a combination of the below-mentioned strategies to strengthen their position in the market:

• Market Penetration: Comprehensive information on the top 15 players in the microbiology testing/clinical microbiology market. The report analyzes the microbiology testing market by application and region; and the clinical microbiology market by product, disease area, end user, and region

• Product Development/Innovation: Detailed insights on research and development activities and new product launches in the microbiology testing/clinical microbiology market

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various microbiology testing products across five geographies (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa)

• Competitive Assessment: Assessment of market shares, strategies, distribution networks, and manufacturing capabilities of the leading players in the clinical microbiology market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 19
1.3.1 MARKETS COVERED 19
1.3.2 GEOGRAPHIC SCOPE 20
1.3.3 YEARS CONSIDERED FOR THE STUDY 20
1.4 CURRENCY AND PRICING 21
1.5 STAKEHOLDERS 21
2 RESEARCH METHODOLOGY 22
2.1 RESEARCH DATA 22
2.1.1 SECONDARY DATA 23
2.1.1.1 Key data from secondary sources 24
2.1.2 PRIMARY DATA 24
2.1.2.1 Key data from primary sources 25
2.1.2.2 Breakdown of primaries 26
2.2 OPPORTUNITY INDICATORS 26
2.2.1 INTRODUCTION 26
2.2.2 DEMAND-SIDE ANALYSIS 27
2.2.2.1 Burden of infectious diseases 27
2.2.2.2 Healthcare expenditure patterns 29
2.2.2.3 Rapid growth in geriatric population 30
2.2.3 SUPPLY-SIDE ANALYSIS 32
2.2.3.1 The number of new products launched as clinical microbiology products 32
2.3 MARKET SIZE ESTIMATION 33
2.3.1 BOTTOM-UP APPROACH 33
2.3.2 TOP-DOWN APPROACH 34
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 35
2.5 RESEARCH LIMITATIONS AND ASSUMPTIONS 36
2.5.1 LIMITATIONS 36
2.5.2 ASSUMPTIONS 36
3 EXECUTIVE SUMMARY 37

4 PREMIUM INSIGHTS 41
4.1 MICROBIOLOGY TESTING MARKET (2018-2023) 41
4.2 MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2018-2023 (USD BILLION) 42
4.3 CLINICAL MICROBIOLOGY MARKET (2018-2023) 43
4.4 CLINICAL MICROBIOLOGY PRODUCTS MARKET, BY REGION (2018) 44
4.5 CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2018 VS. 2023 (USD MILLION) 45
4.6 GEOGRAPHIC ANALYSIS: CLINICAL MICROBIOLOGY MARKET, BY END USER,
2018 VS. 2023 (USD MILLION) 46
5 MARKET OVERVIEW 47
5.1 INTRODUCTION 47
5.2 MARKET DYNAMICS 47
5.2.1 DRIVERS 48
5.2.1.1 Technological advancements in disease diagnostics 48
5.2.1.2 Rising incidence of infectious diseases and growing outbreaks of epidemics 49
5.2.1.3 Increased funding and public-private investments 49
5.2.2 RESTRAINTS 51
5.2.2.1 Limited reimbursement policies for microbiology testing procedures 51
5.2.2.2 Unfavorable regulatory scenario 51
5.2.3 OPPORTUNITIES 52
5.2.3.1 Improving healthcare infrastructure across emerging countries 52
5.2.4 CHALLENGES 54
5.2.4.1 Operational barriers related to the use of diagnostic tests 54
5.2.4.2 Bundled sales of microbiology testing products – A key challenge for small and emerging reagent manufacturers 55
6 MICROBIOLOGY TESTING MARKET, BY APPLICATION 56
6.1 INTRODUCTION 57
6.2 PHARMACEUTICAL APPLICATIONS 58
6.3 CLINICAL APPLICATIONS 59
6.4 FOOD TESTING APPLICATIONS 60
6.5 ENERGY APPLICATIONS 62
6.6 CHEMICAL & MATERIAL MANUFACTURING APPLICATIONS 63
6.7 ENVIRONMENTAL APPLICATIONS 64
7 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT 65
7.1 INTRODUCTION 66
7.2 INSTRUMENTS 67
7.2.1 LABORATORY INSTRUMENTS 68
7.2.1.1 Incubators 72
7.2.1.2 Gram stainers 72
7.2.1.3 Bacterial colony counters 73
7.2.1.4 Autoclave sterilizers 74
7.2.1.5 Microbial air samplers 74
7.2.1.6 Anaerobic culture systems 75
7.2.1.7 Petri dish fillers 76
7.2.1.8 Blood culture systems 76
7.2.1.9 Microbial culture systems 77
7.2.1.10 Other laboratory instruments 78
7.2.2 MICROBIOLOGY ANALYZERS 78
7.2.2.1 Molecular diagnostic instruments 82
7.2.2.2 Microscopes 82
7.2.2.3 Mass spectrometers 83
7.3 REAGENTS 84
7.3.1 PATHOGEN-SPECIFIC KITS 85
7.3.2 GENERAL REAGENTS 88
8 CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA 90
8.1 INTRODUCTION 91
8.2 RESPIRATORY DISEASES 92
8.3 BLOODSTREAM INFECTIONS 94
8.4 GASTROINTESTINAL DISEASES 95
8.5 SEXUALLY TRANSMITTED DISEASES 96
8.6 URINARY TRACT INFECTIONS 97
8.7 PERIODONTAL DISEASES 99
8.8 OTHER DISEASES 100
9 CLINICAL MICROBIOLOGY MARKET, BY END USER 102
9.1 INTRODUCTION 103
9.2 HOSPITALS & DIAGNOSTIC CENTERS 104
9.3 CUSTOM LAB SERVICE PROVIDERS 105
9.4 ACADEMIC & RESEARCH INSTITUTES 106
10 MICROBIOLOGY TESTING/CLINICAL MICROBIOLOGY MARKET, BY REGION 107
10.1 INTRODUCTION 108
10.2 NORTH AMERICA 109
10.2.1 US 114
10.2.2 CANADA 116
10.3 EUROPE 118
10.3.1 GERMANY 124
10.3.2 UK 125
10.3.3 FRANCE 127
10.3.4 REST OF EUROPE 128

10.4 ASIA PACIFIC 130
10.4.1 JAPAN 135
10.4.2 CHINA 136
10.4.3 INDIA 138
10.4.4 REST OF APAC 140
10.5 REST OF THE WORLD (ROW) 142
10.5.1 LATIN AMERICA 146
10.5.2 MIDDLE EAST AND AFRICA 148
11 COMPETITIVE LANDSCAPE 150
11.1 OVERVIEW 150
11.2 MARKET SHARE ANALYSIS 151
11.3 COMPETITIVE SCENARIO 152
11.3.1 KEY PRODUCT LAUNCHES AND APPROVALS (2014–2018) 152
11.3.2 KEY AGREEMENT, PARTNERSHIPS, AND COLLABORATIONS (2014–2018) 152
11.3.3 KEY ACQUISITIONS AND DIVESTMENTS (2014-2018) 153
11.3.4 KEY EXPANSIONS (2014-2018) 154
12 COMPANY PROFILES 155
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 BIOMÉRIEUX 155
12.2 DANAHER CORPORATION 161
12.3 BECTON, DICKINSON AND COMPANY 166
12.4 ABBOTT 170
12.5 ROCHE DIAGNOSTICS (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD.) 177
12.6 BRUKER 181
12.7 HOLOGIC 184
12.8 BIO-RAD 188
12.9 QIAGEN 192
12.10 THERMO FISHER SCIENTIFIC 195
12.11 AGILENT 199
12.12 MERCK KGAA 201
12.13 SHIMADZU 204
12.14 3M 206
12.15 NEOGEN 209

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13 APPENDIX 212
13.1 INSIGHTS OF INDUSTRY EXPERTS 212
13.2 DISCUSSION GUIDE 213
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 218
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 220
13.5 AVAILABLE CUSTOMIZATIONS 221
13.6 RELATED REPORTS 221
13.7 AUTHOR DETAILS 222

LIST OF TABLES

TABLE 1 MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 57
TABLE 2 MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL APPLICATIONS,
BY REGION, 2016–2023 (USD MILLION) 59
TABLE 3 MICROBIOLOGY TESTING MARKET FOR CLINICAL APPLICATIONS,
BY REGION, 2016–2023 (USD MILLION) 60
TABLE 4 MICROBIOLOGY TESTING MARKET FOR FOOD TESTING APPLICATIONS,
BY REGION, 2016–2023 (USD MILLION) 61
TABLE 5 MICROBIOLOGY TESTING MARKET FOR ENERGY APPLICATIONS,
BY REGION, 2016–2023 (USD MILLION) 62
TABLE 6 MICROBIOLOGY TESTING MARKET FOR CHEMICAL AND MATERIAL MANUFACTURING APPLICATIONS, BY REGION, 2016–2023 (USD MILLION) 63
TABLE 7 MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL APPLICATIONS,
BY REGION, 2016–2023 (USD MILLION) 64
TABLE 8 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 66
TABLE 9 CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE,
2016-2023 (USD MILLION) 67
TABLE 10 CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY REGION,
2016-2023 (USD MILLION) 68
TABLE 11 CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET,
BY TYPE, 2016-2023 (USD MILLION) 70
TABLE 12 CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET,
BY REGION, 2016-2023 (USD MILLION) 70
TABLE 13 CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET,
BY DISEASE AREA, 2016-2023 (USD MILLION) 71
TABLE 14 CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET,
BY END USER, 2016-2023 (USD MILLION) 71
TABLE 15 CLINICAL MICROBIOLOGY INCUBATORS MARKET, BY REGION,
2016-2023 (USD MILLION) 72
TABLE 16 CLINICAL MICROBIOLOGY GRAM STAINERS MARKET, BY REGION,
2016-2023 (USD MILLION) 73
TABLE 17 CLINICAL MICROBIOLOGY BACTERIAL COLONY COUNTERS MARKET,
BY REGION, 2016-2023 (USD MILLION) 73
TABLE 18 CLINICAL MICROBIOLOGY AUTOCLAVE STERILIZERS MARKET,
BY REGION, 2016-2023 (USD MILLION) 74
TABLE 19 CLINICAL MICROBIOLOGY MICROBIAL AIR SAMPLERS MARKET,
BY REGION, 2016-2023 (USD MILLION) 75
TABLE 20 CLINICAL MICROBIOLOGY ANAEROBIC CULTURE SYSTEMS MARKET,
BY REGION, 2016-2023 (USD MILLION) 75
TABLE 21 CLINICAL MICROBIOLOGY PETRI DISH FILLERS MARKET, BY REGION,
2016-2023 (USD MILLION) 76
TABLE 22 CLINICAL MICROBIOLOGY BLOOD CULTURE SYSTEMS MARKET,
BY REGION, 2016-2023 (USD MILLION) 77
TABLE 23 CLINICAL MICROBIOLOGY MICROBIAL CULTURE SYSTEMS MARKET,
BY REGION, 2016-2023 (USD MILLION) 77
TABLE 24 CLINICAL MICROBIOLOGY OTHER LABORATORY INSTRUMENTS MARKET,
BY REGION, 2016-2023 (USD MILLION) 78
TABLE 25 CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY TYPE,
2016-2023 (USD MILLION) 80
TABLE 26 CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY REGION,
2016-2023 (USD MILLION) 80
TABLE 27 CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY DISEASE AREA,
2016-2023 (USD MILLION) 81
TABLE 28 CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY END USER,
2016-2023 (USD MILLION) 81
TABLE 29 CLINICAL MICROBIOLOGY MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET,
BY REGION, 2016-2023 (USD MILLION) 82
TABLE 30 CLINICAL MICROBIOLOGY MICROSCOPES MARKET, BY REGION,
2016-2023 (USD MILLION) 83
TABLE 31 CLINICAL MICROBIOLOGY MASS SPECTROMETERS MARKET,
BY REGION, 2016-2023 (USD MILLION) 83
TABLE 32 CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE,
2016-2023 (USD MILLION) 85
TABLE 33 CLINICAL MICROBIOLOGY REAGENTS MARKET, BY REGION,
2016-2023 (USD MILLION) 85
TABLE 34 CLINICAL MICROBIOLOGY PATHOGEN-SPECIFIC KITS MARKET,
BY REGION, 2016-2023 (USD MILLION) 86
TABLE 35 CLINICAL MICROBIOLOGY PATHOGEN-SPECIFIC KITS MARKET,
BY DISEASE AREA, 2016-2023 (USD MILLION) 87
TABLE 36 CLINICAL MICROBIOLOGY PATHOGEN-SPECIFIC KITS MARKET,
BY END USER, 2016-2023 (USD MILLION) 87
TABLE 37 CLINICAL MICROBIOLOGY GENERAL REAGENTS MARKET, BY REGION,
2016-2023 (USD MILLION) 88
TABLE 38 CLINICAL MICROBIOLOGY GENERAL REAGENTS MARKET, BY DISEASE AREA,
2016-2023 (USD MILLION) 88
TABLE 39 CLINICAL MICROBIOLOGY GENERAL REAGENTS MARKET,
BY END USER, 2016-2023 (USD MILLION) 89
TABLE 40 CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2016–2023 (USD MILLION) 92
TABLE 41 CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES,
BY REGION, 2016–2023 (USD MILLION) 93
TABLE 42 CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS,
BY REGION, 2016–2023 (USD MILLION) 94
TABLE 43 CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES,
BY REGION, 2016–2023 (USD MILLION) 96
TABLE 44 CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES,
BY REGION, 2016–2023 (USD MILLION) 97
TABLE 45 CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS,
BY REGION, 2016–2023 (USD MILLION) 98
TABLE 46 CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES,
BY REGION, 2016–2023 (USD MILLION) 100
TABLE 47 CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES, BY REGION,
2016–2023 (USD MILLION) 101
TABLE 48 CLINICAL MICROBIOLOGY MARKET, BY END USER, 2016–2023 (USD MILLION) 103
TABLE 49 CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS,
BY REGION, 2016–2023 (USD MILLION) 104
TABLE 50 CLINICAL MICROBIOLOGY MARKET FOR CUSTOM LAB SERVICE PROVIDERS,
BY REGION, 2016–2023 (USD MILLION) 105
TABLE 51 CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY REGION, 2016–2023 (USD MILLION) 106
TABLE 52 MICROBIOLOGY TESTING MARKET, BY REGION, 2016–2023 (USD MILLION) 108
TABLE 53 CLINICAL MICROBIOLOGY MARKET, BY REGION, 2016–2023 (USD MILLION) 108
TABLE 54 NORTH AMERICA: MICROBIOLOGY TESTING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 111
TABLE 55 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 111
TABLE 56 NORTH AMERICA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 111
TABLE 57 NORTH AMERICA: CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 112
TABLE 58 NORTH AMERICA: CLINICAL MICROBIOLOGY ANALYZERS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 112
TABLE 59 NORTH AMERICA: CLINICAL MICROBIOLOGY REAGENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 113
TABLE 60 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA,
2016–2023 (USD MILLION) 113
TABLE 61 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY END USER,
2016–2023 (USD MILLION) 113
TABLE 62 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 114
TABLE 63 US: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 115
TABLE 64 US: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 115
TABLE 65 US: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 115
TABLE 66 CANADA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 116
TABLE 67 CANADA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 117
TABLE 68 CANADA: CLINICAL MICROBIOLOGY REAGENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 117
TABLE 69 EUROPE: MICROBIOLOGY TESTING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 120
TABLE 70 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 120
TABLE 71 EUROPE: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 120
TABLE 72 EUROPE: CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 121
TABLE 73 EUROPE: CLINICAL MICROBIOLOGY ANALYZERS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 121
TABLE 74 EUROPE: CLINICAL MICROBIOLOGY REAGENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 122
TABLE 75 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA,
2016–2023 (USD MILLION) 122
TABLE 76 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY END USER,
2016–2023 (USD MILLION) 123
TABLE 77 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 123
TABLE 78 GERMANY: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 124
TABLE 79 GERMANY: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 124
TABLE 80 GERMANY: CLINICAL MICROBIOLOGY REAGENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 125
TABLE 81 UK: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 126
TABLE 82 UK: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 126
TABLE 83 UK: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 126
TABLE 84 FRANCE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 127
TABLE 85 FRANCE: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 127
TABLE 86 FRANCE: CLINICAL MICROBIOLOGY REAGENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 128
TABLE 87 ROE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 128
TABLE 88 ROE: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 129
TABLE 89 ROE: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 129
TABLE 90 APAC: MICROBIOLOGY TESTING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 132
TABLE 91 APAC: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 132
TABLE 92 APAC: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 132
TABLE 93 APAC: CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 133
TABLE 94 APAC: CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 133
TABLE 95 APAC: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 134
TABLE 96 APAC: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA,
2016–2023 (USD MILLION) 134
TABLE 97 APAC: CLINICAL MICROBIOLOGY MARKET, BY END USER,
2016–2023 (USD MILLION) 134
TABLE 98 APAC: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 135
TABLE 99 JAPAN: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 135
TABLE 100 JAPAN: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 136
TABLE 101 JAPAN: CLINICAL MICROBIOLOGY REAGENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 136
TABLE 102 CHINA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 137
TABLE 103 CHINA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 138
TABLE 104 CHINA: CLINICAL MICROBIOLOGY REAGENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 138
TABLE 105 INDIA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 139
TABLE 106 INDIA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 139
TABLE 107 INDIA: CLINICAL MICROBIOLOGY REAGENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 140
TABLE 108 ROAPAC: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 140
TABLE 109 ROAPAC: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 141
TABLE 110 ROAPAC: CLINICAL MICROBIOLOGY REAGENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 141
TABLE 111 ROW: MICROBIOLOGY TESTING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 143
TABLE 112 ROW: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 143
TABLE 113 ROW: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 143
TABLE 114 ROW: CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 144
TABLE 115 ROW: CLINICAL MICROBIOLOGY ANALYZERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 144
TABLE 116 ROW: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 145
TABLE 117 ROW: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA,
2016–2023 (USD MILLION) 145
TABLE 118 ROW: CLINICAL MICROBIOLOGY MARKET, BY END USER,
2016–2023 (USD MILLION) 145
TABLE 119 ROW: CLINICAL MICROBIOLOGY MARKET, BY REGION, 2016–2023 (USD MILLION) 146
TABLE 120 LATAM: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 147
TABLE 121 LATAM: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 147
TABLE 122 LATAM: CLINICAL MICROBIOLOGY REAGENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 147
TABLE 123 MEA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 148
TABLE 124 MEA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 148
TABLE 125 MEA: CLINICAL MICROBIOLOGY REAGENTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 149


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 22
FIGURE 2 SOUTH AFRICA AND INDIA HAD THE LARGEST HIV-AIDS PATIENT POPULATION DURING 2010–2016 28
FIGURE 3 HEALTHCARE EXPENDITURE ACROSS MAJOR COUNTRIES: 2005–2015 29
FIGURE 4 HEALTHCARE EXPENDITURE ACROSS MAJOR REGIONS, 2005–2015 29
FIGURE 5 INCREASE IN GERIATRIC POPULATION, BY COUNTRY (2011–2030) 30
FIGURE 6 PERCENTAGE INCREASE IN GERIATRIC POPULATION, BY REGION
(1980–2010 VS. 2010–2040) 31
FIGURE 7 INCREASE IN THE PROPORTION OF GERIATRIC INDIVIDUALS IN THE OVERALL POPULATION, BY COUNTRY (2011–2030) 31
FIGURE 8 THE NUMBER OF NEW PRODUCTS LAUNCHED IN THE CLINICAL MICROBIOLOGY MARKET (2014–2017) 32
FIGURE 9 BOTTOM-UP APPROACH: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET 33
FIGURE 10 TOP-DOWN APPROACH: MICROBIOLOGY TESTING MARKET 34
FIGURE 11 DATA TRIANGULATION 35
FIGURE 12 MICROBIOLOGY TESTING MARKET, BY APPLICATION,
2018 VS. 2023 (USD MILLION) 37
FIGURE 13 CLINICAL MICROBIOLOGY PRODUCTS MARKET, BY REGION (2018) 38
FIGURE 14 CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA (2018 VS. 2023) 39
FIGURE 15 CLINICAL MICROBIOLOGY MARKET SHARE, BY REGION (2018) 40
FIGURE 16 INCREASING GLOBAL BURDEN OF INFECTIOUS DISEASES IS DRIVING THE GROWTH OF THE MICROBIOLOGY TESTING INDUSTRY 41
FIGURE 17 PHARMACEUTICAL APPLICATIONS ARE EXPECTED TO DOMINATE THE MICROBIOLOGY TESTING MARKET DURING THE FORECAST PERIOD 42
FIGURE 18 INCREASED FUNDING AND PUBLIC-PRIVATE INVESTMENT ARE KEY FACTORS DRIVING MARKET GROWTH 43
FIGURE 19 NORTH AMERICA IS EXPECTED TO DOMINATE THE CLINICAL MICROBIOLOGY MARKET, BY PRODUCT 44
FIGURE 20 RESPIRATORY DISEASES ARE EXPECTED TO COMMAND THE LARGEST SHARE OF THE CLINICAL MICROBIOLOGY MARKET DURING THE FORECAST PERIOD 45
FIGURE 21 HOSPITALS AND DIAGNOSTIC CENTERS SEGMENT IS EXPECTED TO DOMINATE THE CLINICAL MICROBIOLOGY MARKETS ACROSS ALL REGIONS UNTIL 2023 46
FIGURE 23 PERCENTAGE CHANGE IN ANNUAL HEALTHCARE EXPENDITURE
— DEVELOPED VS. DEVELOPING COUNTRIES (2005–2015) 54
FIGURE 24 FOOD TESTING APPLICATIONS TO REGISTER THE HIGHEST GROWTH RATE IN THE GLOBAL MICROBIOLOGY TESTING MARKET DURING THE FORECAST PERIOD 57
FIGURE 25 LABORATORY INSTRUMENTS TO DOMINATE THE CLINICAL MICROBIOLOGY INSTRUMENTS MARKET UNTIL 2023 67
FIGURE 26 INCUBATORS TO DOMINATE THE CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET DURING THE FORECAST PERIOD 69
FIGURE 27 MOLECULAR DIAGNOSTIC INSTRUMENTS TO DOMINATE THE CLINICAL MICROBIOLOGY ANALYZERS MARKET UNTIL 2023 79
FIGURE 28 PATHOGEN-SPECIFIC KITS ARE EXPECTED TO COMMAND THE LARGEST SHARE OF THE CLINICAL MICROBIOLOGY REAGENTS MARKET 84
FIGURE 29 RESPIRATORY DISEASES SEGMENT TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 91
FIGURE 30 CUSTOM LAB SERVICE PROVIDERS TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 103
FIGURE 31 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET SNAPSHOT 110
FIGURE 32 EUROPE: CLINICAL MICROBIOLOGY MARKET SNAPSHOT 119
FIGURE 33 APAC: CLINICAL MICROBIOLOGY MARKET SNAPSHOT 131
FIGURE 34 ROW: CLINICAL MICROBIOLOGY MARKET SNAPSHOT 142
FIGURE 35 KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE CLINICAL MICROBIOLOGY MARKET, 2014–2017 150
FIGURE 36 GLOBAL CLINICAL MICROBIOLOGY MARKET SHARE, BY KEY PLAYER, 2017 151
FIGURE 37 BIOMÉRIEUX: COMPANY SNAPSHOT 155
FIGURE 38 DANAHER: COMPANY SNAPSHOT 161
FIGURE 39 BD: COMPANY SNAPSHOT 166
FIGURE 40 ABBOTT: COMPANY SNAPSHOT 170
FIGURE 41 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT 177
FIGURE 42 BRUKER: COMPANY SNAPSHOT 181
FIGURE 43 HOLOGIC: COMPANY SNAPSHOT 184
FIGURE 44 BIO-RAD: COMPANY SNAPSHOT 188
FIGURE 45 QIAGEN: COMPANY SNAPSHOT 192
FIGURE 46 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT 195
FIGURE 47 AGILENT: COMPANY SNAPSHOT 199
FIGURE 48 MERCK KGAA: COMPANY SNAPSHOT 201
FIGURE 49 SHIMADZU: COMPANY SNAPSHOT 204
FIGURE 50 3M: COMPANY SNAPSHOT 206
FIGURE 51 NEOGEN: COMPANY SNAPSHOT 209


★調査レポート[微生物検査/臨床微生物学の世界市場予測(~2023年)] ( Microbiology Testing/Clinical Microbiology Market by Application (Pharma, Clinical, Manufacturing, Environment), Disease (Respiratory Disease, STD, UTI), Product (Instrument, Analyzer, Reagent), End User (Hospital, Diagnolab, Academia) - Global Forecast to 2023 / MD-3092) 販売に関する免責事項
[微生物検査/臨床微生物学の世界市場予測(~2023年)] ( Microbiology Testing/Clinical Microbiology Market by Application (Pharma, Clinical, Manufacturing, Environment), Disease (Respiratory Disease, STD, UTI), Product (Instrument, Analyzer, Reagent), End User (Hospital, Diagnolab, Academia) - Global Forecast to 2023 / MD-3092) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆